Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension

Journal of Hypertension

Volumn 32, Issue 3, 2014, Pages 565-574

  De Ciuceis, Carolina ^a   Salvetti, Massimo ^a   Rossini, Claudia ^a   Muiesan, Maria Lorenza ^a   Paini, Anna ^a   Duse, Sarah ^a   La Boria, Elisa ^a   Semeraro, Francesco ^a   Cancarini, Anna ^a   Rosei, Claudia Agabiti ^a   Sarkar, Annamaria ^a   Ruggeri, Giuseppina ^a   Caimi, Luigi ^a   Ricotta, Doris ^a   Rizzoni, Damiano ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Capillary density; Central blood pressure; Distensibility; Hypertension; Microcirculation; Oxidative stress; Remodeling; Small artery

Indexed keywords

ENALAPRIL; HYDROCHLOROTHIAZIDE; LERCANIDIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY COMPLIANCE; ARTICLE; CAPILLARY DENSITY; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GREAT BLOOD VESSEL; HUMAN; INFLAMMATION; LASER DOPPLER FLOWMETRY; MALE; MICROVASCULATURE; MIDDLE AGED; MONOTHERAPY; MORPHOLOGY; NON INVASIVE MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE WAVE; RETINA ARTERY; SHORT COURSE THERAPY; SKIN CAPILLARY; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARTERIOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DIURETICS; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84894093507     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000067     Document Type: Article

References (44)

1. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921-971.
2. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004; 17 (12 Pt 1):1192-1200.
3. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790.
4. Struijker Boudier HAJ. Microcirculation in hypertension. Eur Heart J 1999; 1 (Suppl L):L32-L37.
5. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ. Microcirculation in hypertension. A new target for treatment? Circulation 2001; 104: 735-740.
6. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34 (4 Pt 1):655-658.
7. Paiardi S, Rodella LF, De Ciuceis C, Porteri E, Boari GE, Rezzani R, et al. Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc 2009; 42:259-268.
8. Safar ME, O'Rourke ME. Handbook of hypertension, volume 23: arterial stiffness in hypertension. Amsterdam, The Netherlands: Elsevier; 2006. p. 598.
9. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
10. Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, et al. Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients. Hypertension 2013; 61:130-136.
11. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
12. Heagerty AM. Predicting hypertension complications from small artery structure. J Hypertens 2007; 25:939-940.
13. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
14. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens 2009; 27:1107-1114.
15. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
16. Touyz RM, Schiffrin EL. Reactive oxygen species and hypertension: a complex association. Antioxid Redox Signal 2008; 10: 1041-1044.
17. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA. Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens 2004; 17:743-748.
18. Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, Salvetti A. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 2001; 37:943-948.
19. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 2007; 112:375-384.
20. Rizzoni D, Porteri E, Duse S, De Ciuceis C, Rosei CA, La Boria E, et al. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens 2012; 30:1169-1175.
21. Bang LM, Chapman TM, Goa KL. Lercanidipine: a review of its efficacy in the management of hypertension. Drugs 2003; 63:2449-2472.
22. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti G, Magagna A, Salvetti A. Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 2003; 41:950-955.
23. Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Griffin M, Cacchio M, et al. Oxygen-free radical decrease in hypertensive patients treated with lercanidipine. Int Angiol 2001; 20:136-140.
24. Borghi C, Cicero AF. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Clin Drug Investig 2010; 30:843-854.
25. Tocci G, Palano F, Pagannone E, Chin D, Ferrucci A, Volpe M. Fixedcombination therapies in hypertension management: focus on enalapril/lercanidipine. Expert Rev Cardiovasc Ther 2009; 7:115-123.
26. Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1153.
27. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992; 5:180-186.
28. Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, et al. Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 2007; 50:623-829.
29. Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, Schmieder RE. Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 2008; 26:1427-1434.
30. De Ciuceis C, Rossini C, Porteri E, La Boria E, Corbellini C, Mittempergher F, et al. Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery. Blood Press 2013; 22:165-172.
31. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33:998-1001.
32. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95:1827-1836.
33. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl 1996; 14:S147-S157.
34. De Ciuceis C, Porteri E, Rizzoni D, Corbellini C, La Boria E, Boari GE, et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension 2011; 58:29-36.
35. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens 1996; 14:1237-1244; 30.
36. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibiriçà E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 2006; 19:477-483.
37. Debbabi H, Bonnin P, Levy BI. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Am J Hypertens 2010; 23:1136-1143.
38. Berkels R, Egink G, Marsen TA, Bartels H, Roesen R, Klaus W. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 2001; 37:240-245.
39. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38 (3 Pt 2):581-587.
40. Zhou MS, Schulman IH, Jaimes EA, Raij L. Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens 2008; 26:494-500.
41. Neutel JM. Metabolic manifestations of low-dose diuretics. Am J Med 1996; 101:71S-82S.
42. Feig DI. The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertens (Greenwich) 2012; 14:346-352.
43. Schiffrin EL. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens 2004; 17 (12 Pt 2):39S-48S.
44. Safar ME, Rizzoni D, Blacher J, Muiesan ML, Agabiti-Rosei E. Macro and microvasculature in hypertension: therapeutic aspects. J Hum Hypertens 2008; 22:590-595.